In vitro investigation of anti-cancer activity of propolis on hepatocellular carcinoma cells

The aim of the current study is to investigate the anti-cancer activity of propolis on liver cancer, with a mechanistic approach. Ethanol extract of the collected propolis was prepared using maceration technique and anti-cancer activity of the extract was investigated on liver hepatocellular carcinoma cells (HepG2 and Hep3B cells) by focusing on viability, intracellular ROS level, total antioxidant status and apoptosis through caspase-3 activity. Total flavonoid content, total phenolic content and ferric reducing antioxidant potential values of the propolis were determined as 505.12±10.08 (mg QE/g), 308.72±5.33 (mg GAE/g) and 247.64±7.27 (mg Tro/g), respectively. Ethanol extract of the propolis induced statistically significant (p < 0.01) decreases in viability of hepatocellular carcinoma cells, HepG2 and Hep3B cells, as evidenced by IC50 values (e.g. IC 50 values of 72 h treated HepG2 and Hep3B cells were 25.62±1.50 and 31.74±2.72 μg/mL, respectively). These powerful cytotoxic effects are caused by statistically significant (p < 0.01) decrease in intracellular ROS level by natural antioxidants such as flavonoids and phenolic acids, as well as statistically significant (p < 0.01) increase in apoptosis induced by caspase-3 activity. These results suggest the great potential of propolis as a potent anti-tumor compound in liver cancer treatment for further researches.

PDF

___

1. Bray F, Ferlay J, Soerjomataram I, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68:394-424.

2. Liu C, Chen K, Chen P. Treatment of liver cancer. Cold Spring Harb Perspect Med. 2015;5:a021535.

3. Sorkun K, Suer B, Salih B. Determination of chemical composition of Turkish propolis. Z Naturforsch. 2001;56:666-8.

4. Vatansever SH, Sorkun K, Gurhan SID, et al. Propolis from Turkey induces apoptosis through activating caspases in human breast carcinoma cell lines. Acta Histochem. 2010;112:546-56.

5. Farooqui T, Farooqui AA. Molecular mechanism underlying the therapeutic activities of propolis: A critical review. Curr Nutr Food Sci. 2010;6:186-99.

6. Turan I, Demir S, Misir S, et al. Cytotoxic effect of Turkish Propolis on liver, colon, breast, cervix and prostate cancer cell lines. Trop J Pharm Res. 2015;14:777-82.

7. Kubiliene L, Laugaliene V, Pavilonis A, et al. Alternative preparation of propolis extracts: comparison of their composition and biological activities. BMC Complement Altern Med. 2015;15:156.

8. Gunduz C, Biray C, Kosova B, et al. Evaluation of Manisa propolis effect on leukemia cell line by telomerase activity. Leuk Res. 2005;29:1343-46.

9. Llovet JM, Zucman-Rossi J, Pikarsky E, et al. Hepatocellular carcinoma. Nat Rev Dis Primers. 2016;2:16018.

10. Ahn MR, Kumazawa S, Usui Y, et al. Antioxidant activity and constituents of propolis collected in various areas of China. Food Chem. 2007;101:1383-92.

11. Singleton VL, Rossi JR. Colorimetry of total phenols with phosphomolybdic-phosphotungstic acid reagents. Am J Enol Vitic. 1965;16:144-58.

12. Mohammadzadeh S, Sharriatpanahi M, Hamedi M, et al. Antioxidant power of Iranian propolisextract. Food Chem. 2007;103:729-33.

13. Aranda A, Sequedo L, Tolosa L, et al. Dichloro-dihydro-fluorescein diacetate (DCFH-DA) assay: a quantitative method for oxidative stress assessment of nanoparticle-treated cells. Toxicol In Vitro. 2013;27:954-63.

14. Orangi M, Pasdaran A, Shanehbandi D, et al. Cytotoxic and apoptotic activities of methanolic subfractions of Scrophularia oxysepala against human breast cancer cell line. Evid Based Complement Alternat Med. 2016;2016:8540640.

15. Ucar M, Deger O, Gerigelmez AY, et al. Effect of Turkish pollen and propolis extracts on caspase-3 activity in myeloid cancer cell lines. Trop J Pharm Res. 2016;15:2445-49.

16. Kumazawa S, Hamasaka T, Nakayama T. Antioxidant activity of propolis of various geographic origins. Food Chem. 2004;84:329-39.

17. Ozdal T, Sari-Kaplan G, Mutlu-Altundag E, et al. Evaluation of Turkish propolis for its chemical composition, antioxidant capacity, anti-proliferative effect on several human breast cancer cell lines and proliferative effect on fibroblasts and mouse mesenchymal stem cell line. J Apic Res. 2018;57:1-12.

18. Misir S, Aliyazicioglu Y, Demir S, et al. Antioxidant properties and protective effect of Turkish propolis on t-BHP-induced oxidative stress in foreskin fibroblast cells. Indian J Pharm Educ. 2018;52:94-100.

19. Kalaycıoğlu Z, Kaygusuz H, Döker S, et al. Characterization of Turkish honeybee pollens by principal component analysis based on their individual organic acids, sugars, minerals, and antioxidant activities. LWT-Food Sci Technol. 2017;84:402-8.

20. Freire KRL, Lins ACS, Dórea MC, et al. Palynological origin, phenolic content, and antioxidant properties of honeybee collected pollen from Bahia, Brazil. Molecules. 2012;17:1652-64.

21. Negri G, Teixeira EW, Alves ML, et al. Hydroxycinnamic acid amide derivatives, phenolic compounds and antioxidant activities of extracts of pollen samples from Southeast Brazil. J Agric Food Chem. 2011;59:5516-22.

22. Kocot J, Kiełczykowska M, Luchowska-Kocot D, et al. Antioxidant potential of propolis, bee pollen, and royal jelly: Possible medical application. Oxid Med Cell Longev. 2018;2018:7074209.

23. Qiu GH, Xie X, Xu F, et al. Distinctive pharmacological differences between liver cancer cell lines HepG2 and Hep3B. Cytotechnology. 2015;67:1-12.

24. Murakami Y, Hayashi K, Hirohashi S, et al. Aberrations of the tumor suppressor p53 and retinoblastoma genes in human hepatocellular carcinomas. Cancer Res. 1991;51:5520-5.

25. Chi TY, Chen GG, Lai PB. Eicosapentaenoic acid induces Fas-mediated apoptosis through a p53-dependent pathway in hepatoma cells. Cancer J. 2004;10:190-200.

26. Choi E, Kim G. Antioxidant and anticancer activity of Artemisia princeps var. orientalis extract in HepG2 and Hep3B hepatocellular carcinoma cells. Chin J Cancer Res. 2013;25:536-43.

27. Žižić JB, Vuković NL, Jadranin MB, et al. Chemical composition, cytotoxic and antioxidative activities of ethanolic extracts of propolis on HCT-116 cell line. J Sci Food Agric. 2013;93:3001-9.

28. Sainz RM, Lombo F, Mayo JC. Radical decisions in cancer: redox control of cell growth and death. Cancers (Basel). 2012;4:442-74.

29. Feitelson MA, Arzumanyan A, Kulathinal RJ, et al. Sustained proliferation in cancer: Mechanisms and novel therapeutic targets. Semin Cancer Biol. 2015;35:S25-54.

30. Liu J, Wang Z. Increased oxidative stress as a selective anticancer therapy. Oxid Med Cell Longev. 2015;2015:294303.

31. Kaushik N, Uddin N, Sim GB, et al. Responses of solid tumor cells in DMEM to reactive oxygen species generated by non-thermal plasma and chemically induced ROS systems. Sci Rep. 2015;5:8587.

32. Cohen GM. Caspases: The executioners of apoptosis. Biochem J. 1997;326:1-16.

33. Janicke RU, Sprengart ML, Wati MR, et al. Caspase-3 is required for DNA fragmentation and morphological changes associated with apoptosis. J Biol Chem. 1998;273:9357-60.

34. Eom HS, Lee EJ, Yoon BS, et al. Propolis inhibits the proliferation of human leukaemia HL-60 cells by inducing apoptosis through the mitochondrial pathway. Nat Prod Res. 2010;24:375-86.

35. Watkins R, Wu L, Zhang C, et al. Natural product-based nanomedicine: recent advances and issues. Int J Nanomedicine. 2015;10:6055-74.

36. Bilia AR, Piazzini V, Guccione C, et al. Improving on nature: The role of nanomedicine in the development of clinical natural drugs. Planta Med. 2017;83(5):366-81.

37. Bilia AR, Piazzini V, Risaliti L, et al. Nanocarriers: A successful tool to increase solubility, stability and optimise bioefficacy of natural constituents. Curr Med Chem. 2018;[Epub ahead of print]

38. Gokduman K, Demir AS. Camptothecin anticancer drug loaded iron oxide micro and nanoparticles: Tuning targeted and sustained release of the drug in bioactive form. Curr Nanosci. 2013;9:704-10.

39. Gokduman K. Strategies targeting DNA topoisomerase I in cancer chemotherapy: Camptothecins, nanocarriers for camptothecins, organic non-camptothecin compounds and metal complexes. Curr Drug Targets. 2016;17:1928-39.

40. Gokduman K, Bestepe F, Li L, et al. Dose-, treatment- and time-dependent toxicity of superparamagnetic iron oxide nanoparticles on primary rat hepatocytes. Nanomedicine. 2018;13:1267-84.